Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03158506 · ClinicalTrials.gov registry record · Phase 1
Human Mass Balance Study of HMS5552 in Healthy Subjects
A Phase 1 study, sponsored by Hua Medicine Limited.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT03158506 is a Phase 1 study that has completed, run by Hua Medicine Limited. The registered enrollment target is 6 participants.
The verdict
NCT03158506, a Phase 1 study, has completed, sponsored by Hua Medicine Limited.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is an open-label, single center, 1-period study in healthy adult male subjects to assess absorption, metabolism, and excretion of HMS5552 after a single oral administration of 50 mg (90 μCi) of \[14C\]-HMS5552.
Interventions
- DRUG HMS5552
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2017-03-29 |
| Est. Completion | 2017-04-06 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03158506
The ClinicalTrials.gov registry entry for NCT03158506 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hua Medicine Limited, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HMS5552 is the first listed.
NCT03158506 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03158506 about?
NCT03158506 is a clinical study titled "Human Mass Balance Study of HMS5552 in Healthy Subjects". This is an open-label, single center, 1-period study in healthy adult male subjects to assess absorption, metabolism, and excretion of HMS5552 after a single oral administration of 50 mg (90 μCi) of \[14C\]-HMS5552.
What is the current status of trial NCT03158506?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2017-03-29. Estimated completion is 2017-04-06.
What interventions are being tested in trial NCT03158506?
The interventions under investigation include: HMS5552 (DRUG).
Who is sponsoring clinical trial NCT03158506?
This trial is sponsored by Hua Medicine Limited, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.